Levin W, Chang R L, Wood A W, Yagi H, Thakker D R, Jerina D M, Conney A H
Cancer Res. 1984 Mar;44(3):929-33.
The tumorigenicity of the (+)- and (-)-enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides was evaluated in two mouse tumor models. In an initiation-promotion experiment on mouse skin, a single topical application of 0.1 or 0.4 mumol of the benz(a)anthracene diol-epoxides was followed by 25 weeks of promotion with 12-O-tetradecanoylphorbol-13-acetate. Of the four isomers of the bay-region diol-epoxides, only (+)-[1R,2S,3S,4R]-3,4-dihydroxy-1,2-epoxy-1,2,3,4- tetrahydrobenz(a)anthracene [(+)-diol-epoxide-2] and (+)-[1R,2S,3S,4S]-3,4-dihydroxy-1,2-epoxy-1,2,3,4- tetrahydrobenz(a)anthracene [(+)-diol-epoxide-1] had significant tumor-initiating activity. (+)-Diol-epoxide-2 was approximately 4-fold more active as a tumor initiator on mouse skin than was (+)-diolepoxide-1 at both doses tested. In newborn mice, a total of 0.14 mumol of compound, divided into three doses, was administered i.p. on the first, eighth, and fifteenth day of life, and tumorigenic activity was determined when the mice were 26 to 32 weeks of age. As was observed in the initiation-promotion experiment on mouse skin, only two of the four optical isomers of the bay-region diol-epoxides produced a significant tumor incidence. (+)-Diol-epoxide-2 induced a 100% incidence of lung tumors, with an average of 23.11 tumors/mouse, and was at least 60-fold more active (average number of tumors per mouse) than was (+)-diol-epoxide-1, which produced a 31% lung tumor incidence and 0.38 lung tumors/mouse. (+)-Diol-epoxide-2 was the only optical isomer that induced a significant incidence of hepatic tumors in male mice (31% incidence, 1.17 tumors/mouse). The highly tumorigenic (+)-diol-epoxide-2 isomer with [R,S,S,R] absolute configuration has the same absolute configuration as does the highly tumorigenic isomer of the bay-region diol-epoxides of benzo(a)pyrene and chrysene.
在两种小鼠肿瘤模型中评估了非对映体湾区苯并(a)蒽3,4 -二醇 - 1,2 - 环氧化物的(+)-和(-)-对映体的致瘤性。在小鼠皮肤的启动 - 促进实验中,局部单次应用0.1或0.4 μmol苯并(a)蒽二醇环氧化物,随后用12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯进行25周的促进。在湾区二醇环氧化物的四种异构体中,只有(+)-[1R,2S,3S,4R]-3,4 - 二羟基 - 1,2 - 环氧 - 1,2,3,4 - 四氢苯并(a)蒽[(+)-二醇环氧化物 - 2]和(+)-[1R,2S,3S,4S]-3,4 - 二羟基 - 1,2 - 环氧 - 1,2,3,4 - 四氢苯并(a)蒽[(+)-二醇环氧化物 - 1]具有显著的肿瘤启动活性。在测试的两种剂量下,(+)-二醇环氧化物 - 2作为小鼠皮肤肿瘤启动剂的活性比(+)-二醇环氧化物 - 1高约4倍。在新生小鼠中,在出生后的第1、8和15天,分三次腹腔注射总共0.14 μmol的化合物,并在小鼠26至32周龄时测定致瘤活性。正如在小鼠皮肤启动 - 促进实验中所观察到的,湾区二醇环氧化物的四种光学异构体中只有两种产生了显著的肿瘤发生率。(+)-二醇环氧化物 - 2诱导肺肿瘤的发生率为100%,平均每只小鼠有23.11个肿瘤,其活性(平均每只小鼠的肿瘤数量)比(+)-二醇环氧化物 - 1至少高60倍,(+)-二醇环氧化物 - 1产生31%的肺肿瘤发生率,每只小鼠有0.38个肺肿瘤。(+)-二醇环氧化物 - 2是唯一一种在雄性小鼠中诱导显著肝肿瘤发生率的光学异构体(发生率为?31%,每只小鼠有1.17个肿瘤)。具有[R,S,S,R]绝对构型的高致瘤性(+)-二醇环氧化物 - 2异构体与苯并(a)芘和 Chrysene 的湾区二醇环氧化物的高致瘤性异构体具有相同的绝对构型。 (注:原文中“31% incidence”这里翻译为“31%发生率”,因为后面括号里“1.17 tumors/mouse”是每只小鼠肿瘤数量,这里前面的“31%”应该指发生率,原文表述不太清晰,译文尽量按原文逻辑翻译。)